Results of the TRIGGER-PCI trial reported at TCT 2011
Wednesday, November 9, 2011 - 16:32
in Health & Medicine
A clinical trial comparing prasugrel to clopidogrel for patients with high on-clopidogrel platelet reactivity (HCPR) following percutaneous coronary intervention (PCI) was ended early due to relatively few occurrences of cardiac death or myocardial infarction the primary endpoint at six month follow up.